Alpha 2.0
Login Register
» Articles » PMID: 9053513

Critical Role of Phase I Clinical Trials in Cancer Treatment. American Society of Clinical Oncology

Overview
Journal J Clin Oncol
Specialty Oncology
Date 1997 Feb 1
PMID 9053513
Citations 13
Affiliations
Soon will be listed here.
Citing Articles

Early-Phase Platform Trials: A New Paradigm for Dose Finding and Treatment Screening in the Era of Precision Oncology.

Polley M, Cheung Y JCO Precis Oncol. 2020; 3.

PMID: 32923846 PMC: 7446322. DOI: 10.1200/PO.19.00057.

Proportion of Patients in Phase I Oncology Trials Receiving Treatments That Are Ultimately Approved.

Zhang S, Fergusson D, Kimmelman J J Natl Cancer Inst. 2020; 112(9):886-892.

PMID: 32239146 PMC: 7492767. DOI: 10.1093/jnci/djaa044.

Pragmatic dose-escalation methods incorporating relative dose intensity assessment for molecularly targeted agents in phase I trials.

Hirakawa A, Tanaka Y, Kaneko S Contemp Clin Trials Commun. 2019; 16:100489.

PMID: 31799475 PMC: 6883296. DOI: 10.1016/j.conctc.2019.100489.

Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose-finding trials.

Hirakawa A, Yonemori K, Kinoshita F, Kobayashi Y, Okuma H, Kawachi A Cancer Sci. 2017; 109(1):207-214.

PMID: 29114963 PMC: 5765308. DOI: 10.1111/cas.13436.

How do researchers decide early clinical trials?.

Grankvist H, Kimmelman J Med Health Care Philos. 2016; 19(2):191-8.

PMID: 26833467 DOI: 10.1007/s11019-016-9685-6.